The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

Objectives The optimal maternal age at childbirth has been a topic of bourgeoning literature, with earlier ages offering physiological benefits for maternal recovery. In contrast, later ages to give ...

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...

Global healthcare spending is $9.8 trillion annually, with the U.S. accounting for about $4.9 trillion. Investors can consider drug, medical device, payer, and healthcare provider stocks. Focus on ...